Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention

The newly proposed term “metabolic dysfunction-associated fatty liver disease” (MAFLD) is replacing the old term “non-alcoholic fatty liver disease” (NAFLD) in many global regions, because it better reflects the pathophysiology and cardiometabolic implications of this common liver disease. The propo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiao-Dong, Cai, Jingjing, Targher, Giovanni, Byrne, Christopher D., Shapiro, Michael D., Sung, Ki-Chul, Somers, Virend K., Chahal, C. Anwar A., George, Jacob, Chen, Li-Li, Zhou, Yong, Zheng, Ming-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719631/
https://www.ncbi.nlm.nih.gov/pubmed/36463192
http://dx.doi.org/10.1186/s12933-022-01697-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719631/
https://www.ncbi.nlm.nih.gov/pubmed/36463192
http://dx.doi.org/10.1186/s12933-022-01697-0

Ejemplares similares